• Price (--)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Revvity, Inc., formerly PerkinElmer, Inc., is a provider of products, services and solutions for the diagnostics and life sciences. The Company operates in two segments: Life Sciences and Diagnostics. The Diagnostics segment provides products and services targeted towards the life sciences markets. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the reproductive health, immunodiagnostics, and applied genomics markets.

  • Revenue in USD (TTM)2.73bn
  • Net income in USD360.52m
  • Incorporated1947
  • Employees16.70k
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.